A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany.

MLA

Siefen, Ann-Cathrine, et al. “A Retrospective Budget Impact Analysis of Fidaxomicin Treatment for Clostridioides Difficile Infections (CDI) in Germany.” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 24, no. 8, Oct. 2024, pp. 933–42. EBSCOhost, https://doi.org/10.1080/14737167.2024.2352005.

APA

Siefen, A.-C., Kurte, M. S., Bauer, A. M., Cornely, O. A., Wingen-Heimann, S., & Kron, F. (2024). A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany. Expert Review of Pharmacoeconomics & Outcomes Research, 24(8), 933–942. https://doi.org/10.1080/14737167.2024.2352005

Chicago

Siefen, Ann-Cathrine, Melina Sophie Kurte, Anna Marie Bauer, Oliver A Cornely, Sebastian Wingen-Heimann, and Florian Kron. 2024. “A Retrospective Budget Impact Analysis of Fidaxomicin Treatment for Clostridioides Difficile Infections (CDI) in Germany.” Expert Review of Pharmacoeconomics & Outcomes Research 24 (8): 933–42. doi:10.1080/14737167.2024.2352005.